At our Gaithersburg clinic, providers review symptoms, medical history, and prior ED therapies before determining whether PT-141 is clinically appropriate
According to results published in NEJM, Mounjaro achieved A1C reductions of 2.01% (5mg), 2.24% (10mg), and 2.30% (15mg) versus 1.86% with semaglutide 1mg
For example, some early studies suggest that individuals with C677T and A1298C variants are more likely to develop heart disease
GLP-1 medications generally aren't appropriate with: Personal/family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia type 2 (MEN 2) History of pancreatitis Severe gastroparesis or GI motility disorders Pregnancy, trying to conceive, or breastfeeding A history of eating disorders (requires careful evaluation) Josh reviews your full history at your consult to confirm treatment is safe for you
Genetic factors that affect risk of alcoholic and nonalcoholic fatty liver disease